Merit Medical Systems, Inc. (NASDAQ:MMSI) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Key Points

• "Moderate Buy" consensus from 10 analysts—seven "buy" and three "hold"—with an average 1‑year price target of about $99.56.
• Merit beat Q results with $1.04 EPS versus $0.96 expected and revenue up 10.9% year‑over‑year, and it set FY2026 guidance of 4.010–4.150 EPS.
• Shares trade near $64.84 (down 2.8%), well below analyst targets and its 12‑month high of $100.19, while institutional investors own roughly 99.66% of the stock.

Merit Medical Systems, Inc. (NASDAQ:MMSI - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the ten research firms that are presently covering the company, MarketBeat.com reports. Three analysts have rated the stock with a hold rating and seven have issued a buy rating on the company. The average 1-year price target among brokerages that have issued a report on the stock in the last year is $99.5556.

A number of analysts recently commented on MMSI shares. Needham & Company LLC reiterated a "buy" rating and issued a $101.00 target price on shares of Merit Medical Systems in a report on Wednesday, April 1st. Canaccord Genuity Group dropped their target price on shares of Merit Medical Systems from $99.00 to $90.00 and set a "buy" rating on the stock in a report on Tuesday, April 7th. BTIG Research began coverage on shares of Merit Medical Systems in a report on Friday, February 6th. They set a "buy" rating and a $107.00 price target on the stock. Weiss Ratings restated a "hold (c)" rating on shares of Merit Medical Systems in a report on Friday, March 27th. Finally, Compass Point set a $107.00 price target on shares of Merit Medical Systems in a report on Monday, April 20th.

Merit Medical Systems Stock Down 2.8%

NASDAQ MMSI opened at $64.84 on Thursday. The company has a debt-to-equity ratio of 0.46, a current ratio of 4.34 and a quick ratio of 2.95. The company's 50 day simple moving average is $70.95 and its 200 day simple moving average is $79.86. Merit Medical Systems has a 12 month low of $63.78 and a 12 month high of $100.19. The company has a market capitalization of $3.87 billion, a P/E ratio of 30.58, a PEG ratio of 1.90 and a beta of 0.64.

Merit Medical Systems (NASDAQ:MMSI - Get Free Report) last released its earnings results on Tuesday, February 24th. The medical instruments supplier reported $1.04 EPS for the quarter, topping analysts' consensus estimates of $0.96 by $0.08. Merit Medical Systems had a net margin of 8.48% and a return on equity of 13.82%. The business had revenue of $393.94 million for the quarter, compared to the consensus estimate of $390.77 million. During the same period in the previous year, the firm earned $0.93 EPS. The business's revenue for the quarter was up 10.9% on a year-over-year basis. Merit Medical Systems has set its FY 2026 guidance at 4.010-4.150 EPS. Equities research analysts expect that Merit Medical Systems will post 3.62 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Merit Medical Systems

A number of large investors have recently made changes to their positions in the company. Ascentis Independent Advisors acquired a new stake in shares of Merit Medical Systems during the first quarter valued at approximately $506,000. Y Intercept Hong Kong Ltd acquired a new position in Merit Medical Systems in the 1st quarter valued at approximately $2,919,000. Elevation Point Wealth Partners LLC acquired a new position in Merit Medical Systems in the 1st quarter valued at approximately $353,000. Boston Trust Walden Corp acquired a new position in Merit Medical Systems in the 1st quarter valued at approximately $19,108,000. Finally, Conestoga Capital Advisors LLC increased its stake in Merit Medical Systems by 3.9% in the 1st quarter. Conestoga Capital Advisors LLC now owns 2,167,513 shares of the medical instruments supplier's stock valued at $149,407,000 after buying an additional 81,030 shares during the period. Institutional investors and hedge funds own 99.66% of the company's stock.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company's product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.